Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bessi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancers|November 28, 2013
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancerCatherine Oakman, Marta Pestrin, Silvia Bessi, et al.
Breast Cancer Research : BCR|May 14, 2009
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancerCatherine Oakman, Silvia Bessi, Elena Zafarana, et al.
Journal of Clinical Pathology|February 16, 2020
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumoursSilvia Bessi, Francesco Pepe, Marco Ottaviantonio, et al.
Breast Cancer Research and Treatment|July 15, 2009
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsMarta Pestrin, Silvia Bessi, Francesca Galardi, et al.
Journal of Clinical Pathology|June 14, 2022
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre studySilvia Bessi, Francesco Pepe, Gianluca Russo, et al.
Breast (Edinburgh, Scotland)|March 13, 2012
Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patientsFrancesca Galardi, Catherine Oakman, Maria Caterina Truglia, et al.
Breast Cancer Research and Treatment|April 6, 2012
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept studyMarta Pestrin, Silvia Bessi, Fabio Puglisi, et al.
Pathologica|September 18, 2025
Part II - Analytical phaseElena Guerini-Rocco, Konstantinos Venetis, Silvia Bessi, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|November 28, 2013
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancerCatherine Oakman, Marta Pestrin, Silvia Bessi, et al.
Breast Cancer Research : BCR|May 14, 2009
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancerCatherine Oakman, Silvia Bessi, Elena Zafarana, et al.
Journal of Clinical Pathology|February 16, 2020
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumoursSilvia Bessi, Francesco Pepe, Marco Ottaviantonio, et al.
Breast Cancer Research and Treatment|July 15, 2009
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsMarta Pestrin, Silvia Bessi, Francesca Galardi, et al.
Journal of Clinical Pathology|June 14, 2022
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre studySilvia Bessi, Francesco Pepe, Gianluca Russo, et al.
Breast (Edinburgh, Scotland)|March 13, 2012
Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patientsFrancesca Galardi, Catherine Oakman, Maria Caterina Truglia, et al.
Breast Cancer Research and Treatment|April 6, 2012
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept studyMarta Pestrin, Silvia Bessi, Fabio Puglisi, et al.
Pathologica|September 18, 2025
Part II - Analytical phaseElena Guerini-Rocco, Konstantinos Venetis, Silvia Bessi, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
Pageof 2